JP2024518429A - 4-[5-[(3s)-3-アミノピロリジン-1-カルボニル]-2-[2-フルオロ-4-(2-ヒドロキシ-2-エチルプロピル)フェニル]フェニル]-2-フルオロ-ベンゾニトリルの塩の固体形態 - Google Patents
4-[5-[(3s)-3-アミノピロリジン-1-カルボニル]-2-[2-フルオロ-4-(2-ヒドロキシ-2-エチルプロピル)フェニル]フェニル]-2-フルオロ-ベンゾニトリルの塩の固体形態 Download PDFInfo
- Publication number
- JP2024518429A JP2024518429A JP2023568486A JP2023568486A JP2024518429A JP 2024518429 A JP2024518429 A JP 2024518429A JP 2023568486 A JP2023568486 A JP 2023568486A JP 2023568486 A JP2023568486 A JP 2023568486A JP 2024518429 A JP2024518429 A JP 2024518429A
- Authority
- JP
- Japan
- Prior art keywords
- compound
- crystalline form
- cancer
- solvent
- diffraction pattern
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/14—Nitrogen atoms not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163187125P | 2021-05-11 | 2021-05-11 | |
| US63/187,125 | 2021-05-11 | ||
| PCT/US2022/028606 WO2022240886A1 (en) | 2021-05-11 | 2022-05-10 | Solid forms of salts of 4-[5-[(3s)-3-aminopyrrolidine-1-carbonyl]-2-[2-fluoro-4-(2-hydroxy-2-ethylpropyl)phenyl]phenyl]-2-fluoro-benzonitrile |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024518429A true JP2024518429A (ja) | 2024-05-01 |
| JP2024518429A5 JP2024518429A5 (cg-RX-API-DMAC7.html) | 2025-05-20 |
Family
ID=81854861
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023568486A Pending JP2024518429A (ja) | 2021-05-11 | 2022-05-10 | 4-[5-[(3s)-3-アミノピロリジン-1-カルボニル]-2-[2-フルオロ-4-(2-ヒドロキシ-2-エチルプロピル)フェニル]フェニル]-2-フルオロ-ベンゾニトリルの塩の固体形態 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240228438A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4337638A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024518429A (cg-RX-API-DMAC7.html) |
| CN (1) | CN117769540A (cg-RX-API-DMAC7.html) |
| TW (1) | TW202308991A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022240886A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20250295660A1 (en) | 2022-05-09 | 2025-09-25 | Oryzon Genomics, S.A. | Methods of treating nf1-mutant tumors using lsd1 inhibitors |
| US20250275969A1 (en) | 2022-05-09 | 2025-09-04 | Oryzon Genomics, S.A. | Methods of treating malignant peripheral nerve sheath tumor (mpnst) using lsd1 inhibitors |
| US20260151399A1 (en) | 2022-11-24 | 2026-06-04 | Oryzon Genomics, S.A. | Combinations of lsd1 inhibitors and menin inhibitors for treating cancer |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2013542258A (ja) * | 2010-11-10 | 2013-11-21 | セラヴァンス, インコーポレーテッド | アルコキシイミダゾール−1−イルメチルビフェニルカルボン酸の結晶性形態 |
| WO2017006968A1 (ja) * | 2015-07-07 | 2017-01-12 | 日本たばこ産業株式会社 | 7H-ピロロ[2,3-d]ピリミジン誘導体の製造方法及びその中間体 |
| WO2017090756A1 (ja) * | 2015-11-27 | 2017-06-01 | 大鵬薬品工業株式会社 | 新規なビフェニル化合物又はその塩 |
| JP2020503330A (ja) * | 2016-12-28 | 2020-01-30 | トニックス ファーマ ホールディングス リミテッド | チアネプチンシュウ酸塩および多形 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2022005811A (es) * | 2019-11-13 | 2022-06-08 | Taiho Pharmaceutical Co Ltd | Sal novedosa de compuesto de terfenilo. |
-
2022
- 2022-05-10 CN CN202280034492.9A patent/CN117769540A/zh active Pending
- 2022-05-10 US US18/560,360 patent/US20240228438A1/en active Pending
- 2022-05-10 WO PCT/US2022/028606 patent/WO2022240886A1/en not_active Ceased
- 2022-05-10 TW TW111117524A patent/TW202308991A/zh unknown
- 2022-05-10 EP EP22726922.2A patent/EP4337638A1/en not_active Withdrawn
- 2022-05-10 JP JP2023568486A patent/JP2024518429A/ja active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2013542258A (ja) * | 2010-11-10 | 2013-11-21 | セラヴァンス, インコーポレーテッド | アルコキシイミダゾール−1−イルメチルビフェニルカルボン酸の結晶性形態 |
| WO2017006968A1 (ja) * | 2015-07-07 | 2017-01-12 | 日本たばこ産業株式会社 | 7H-ピロロ[2,3-d]ピリミジン誘導体の製造方法及びその中間体 |
| WO2017090756A1 (ja) * | 2015-11-27 | 2017-06-01 | 大鵬薬品工業株式会社 | 新規なビフェニル化合物又はその塩 |
| JP2020503330A (ja) * | 2016-12-28 | 2020-01-30 | トニックス ファーマ ホールディングス リミテッド | チアネプチンシュウ酸塩および多形 |
Non-Patent Citations (3)
| Title |
|---|
| C.G.WERMUTH編, 最新 創薬化学 下巻, JPN6014029314, 1999, pages 347 - 365, ISSN: 0005891885 * |
| 芦澤一英, 医薬品の多形現象と晶析の科学, JPN6015027444, 2002, pages 273 - 278, ISSN: 0005891883 * |
| 高田則幸: "創薬段階における原薬Formスクリーニングと選択", PHARM STAGE, vol. 6, no. 10, JPN6009053755, 15 January 2007 (2007-01-15), pages 20 - 25, ISSN: 0005891884 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN117769540A (zh) | 2024-03-26 |
| WO2022240886A1 (en) | 2022-11-17 |
| EP4337638A1 (en) | 2024-03-20 |
| TW202308991A (zh) | 2023-03-01 |
| US20240228438A1 (en) | 2024-07-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI874490B (zh) | 三苯化合物之新穎鹽類 | |
| AU2020276695A1 (en) | New crystalline forms of N-(3-(2-(2-hydroxyethoxy)-6-morpholinopyridin-4-yl)-4-methvlphenyl)-2 (trifluoromethyl)isonicotinamide as Raf inhibitors for the treatment of cancer | |
| US20240228438A1 (en) | Solid forms of salts of 4-[5-[(3s)-3-aminopyrrolidine-1-carbonyl]-2-[2-fluoro-4-(2- hydroxy-2-ethylpropyl)phenyl]phenyl]-2-fluoro-benzonitrile | |
| JP2022068350A (ja) | N-(4-((3-(2-アミノ-4-ピリミジニル)-2-ピリジニル)オキシ)フェニル)-4-(4-メチル-2-チエニル)-1-フタラジンアミンの薬学的に許容される塩の結晶形態及びその使用 | |
| JP2025131661A (ja) | 2-(5-(4-(2-モルホリノエトキシ)フェニル)ピリジン-2-イル)-n-ベンジルアセトアミドの固体形態 | |
| EP2542548A1 (en) | Process for preparation of polymorphic form and new polymorphic form of imatinib mesylate isolated in that process | |
| EP4631937A1 (en) | Crystalline form or amorphous form of oxoisoindole-5-formamide compound or salt and solvate thereof | |
| CN109843880B (zh) | 4-(2-((1r,2r)-2-羟基环己基氨基)苯并噻唑-6-基氧基)-n-甲基吡啶酰胺的晶型 | |
| JP7618575B2 (ja) | N-(5-((4-エチルピペラジン-1-イル)メチル)ピリジン-2-イル)-5-フルオロ-4-(3-イソプロピル-2-メチル-2h-インダゾール-5-イル)ピリミジン-2-アミンおよびその塩の結晶形態および非晶質形態、ならびにその製造方法および治療的使用 | |
| KR102858471B1 (ko) | Lta4h 저해제의 결정질 형태 | |
| HK40108981A (en) | Solid forms of salts of 4-[5-[(3s)-3-aminopyrrolidine-1-carbonyl]-2-[2-fluoro-4-(2-hydroxy-2-ethylpropyl)phenyl]phenyl]-2-fluoro-benzonitrile | |
| JP7788550B2 (ja) | ターフェニル化合物の安息香酸塩の製造方法 | |
| EP2345649A1 (en) | Benzimidazole compound in crystal form and salt thereof | |
| RU2802964C2 (ru) | Твердые формы 2-(5-(4-(2-морфолиноэтокси)фенил)пиридин-2-ил)-n-бензилацетамида | |
| KR102963137B1 (ko) | 벤조티아졸 화합물의 약제학적 염, 다형체 및 이들의 제조 방법 | |
| CN121941687A (zh) | 一种丙烯酰胺类化合物的晶型vi及其制备方法和用途 | |
| KR20260074339A (ko) | Parg 억제제 | |
| BR112021022335B1 (pt) | Formas cristalinas de n-(3-(2-(2-hidroxietoxi)-6-morfolinopiridin4-il)-4- metilfenil)-2 (trifluorome-til)isonicotinamida como inibidores raf, seus usos, e composição farmacêutica | |
| HK40076742A (en) | Novel salt of terphenyl compound |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20250512 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20250512 |
|
| A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20250620 Free format text: JAPANESE INTERMEDIATE CODE: A712 Effective date: 20250620 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20250620 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20260115 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20260203 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20260623 |